Sector Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
04:00:00 2026-08-21 pm EDT
|
5-day change | 1st Jan Change | ||
| 56.50 USD | +2.26% |
|
+7.58% | +28.26% |
| Aug. 21 | Scholar Rock's Global Regulatory Path Further De-Risked, Wedbush Says | MT |
| Aug. 21 | Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.88B | - | - | - | - | - |
| 72.12B | |||||
| 65.85B | |||||
| 29.28B | - | ||||
| 27.47B | - | ||||
| 26.7B |
Select your edition
All financial news and data tailored to specific country editions
